226 related articles for article (PubMed ID: 31271757)
41. Integrating precision cancer medicine into healthcare-policy, practice, and research challenges.
Bertier G; Carrot-Zhang J; Ragoussis V; Joly Y
Genome Med; 2016 Oct; 8(1):108. PubMed ID: 27776531
[TBL] [Abstract][Full Text] [Related]
42. Understanding the Barriers to Genomic Healthcare in Queensland Through an Information Management Lens.
Bradford DK; Pearson J; Gorse D; Metke A; Leroux H; Dallest K; Bunker D; Hansen D
Stud Health Technol Inform; 2019 Aug; 266():37-43. PubMed ID: 31397299
[TBL] [Abstract][Full Text] [Related]
43. Using Data Integration to Improve Health and Welfare Insights.
Jensen LR
Int J Environ Res Public Health; 2022 Jan; 19(2):. PubMed ID: 35055659
[TBL] [Abstract][Full Text] [Related]
44. Making good on the promise of genomics in healthcare: the NSW Health perspective.
Willcox D; Trent RJA; Lyons N; Meldrum C; Kennedy P; Lee T; Berman Y; Burgess B; Cannings JW; Canova MJ; Halliburton C; Hibbitt O; Norris SK; Penna A; Perkins A; Pilowsky E; Rushton S
Aust Health Rev; 2023 Dec; 47(6):631-633. PubMed ID: 37844625
[TBL] [Abstract][Full Text] [Related]
45. New Diagnostic Approaches for Undiagnosed Rare Genetic Diseases.
Hartley T; Lemire G; Kernohan KD; Howley HE; Adams DR; Boycott KM
Annu Rev Genomics Hum Genet; 2020 Aug; 21():351-372. PubMed ID: 32283948
[TBL] [Abstract][Full Text] [Related]
46. An evaluation of the quality of evidence underpinning diabetes management models: a review of the literature.
Schofield D; Cunich MM; Naccarella L
Aust Health Rev; 2014 Nov; 38(5):495-505. PubMed ID: 25088795
[TBL] [Abstract][Full Text] [Related]
47. [Genomic revolution of rare disease diagnosis].
Mandel JL
Presse Med; 2012 May; 41 Suppl 1():S26-8. PubMed ID: 22503291
[No Abstract] [Full Text] [Related]
48. Controversy and debate on clinical genomics sequencing-paper 1: genomics is not exceptional: rigorous evaluations are necessary for clinical applications of genomic sequencing.
Wilson BJ; Miller FA; Rousseau F
J Clin Epidemiol; 2017 Dec; 92():4-6. PubMed ID: 28870871
[TBL] [Abstract][Full Text] [Related]
49. Research in Rare Disease: From Genomics to Proteomics.
Lacoste J
Assay Drug Dev Technol; 2018 Jan; 16(1):12-14. PubMed ID: 29345978
[TBL] [Abstract][Full Text] [Related]
50. Smart Medical Information Technology for Healthcare (SMITH).
Winter A; Stäubert S; Ammon D; Aiche S; Beyan O; Bischoff V; Daumke P; Decker S; Funkat G; Gewehr JE; de Greiff A; Haferkamp S; Hahn U; Henkel A; Kirsten T; Klöss T; Lippert J; Löbe M; Lowitsch V; Maassen O; Maschmann J; Meister S; Mikolajczyk R; Nüchter M; Pletz MW; Rahm E; Riedel M; Saleh K; Schuppert A; Smers S; Stollenwerk A; Uhlig S; Wendt T; Zenker S; Fleig W; Marx G; Scherag A; Löffler M
Methods Inf Med; 2018 Jul; 57(S 01):e92-e105. PubMed ID: 30016815
[TBL] [Abstract][Full Text] [Related]
51. Next-generation sequencing applied to rare diseases genomics.
Danielsson K; Mun LJ; Lordemann A; Mao J; Lin CH
Expert Rev Mol Diagn; 2014 May; 14(4):469-87. PubMed ID: 24702023
[TBL] [Abstract][Full Text] [Related]
52. Better than a crystal ball? Using simulation to foresee emerging issues in the Australian Healthcare System.
Bolton P; Power P
World Hosp Health Serv; 2011; 47(3):31-3. PubMed ID: 22235726
[TBL] [Abstract][Full Text] [Related]
53. Systems Medicine: The Future of Medical Genomics, Healthcare, and Wellness.
Saqi M; Pellet J; Roznovat I; Mazein A; Ballereau S; De Meulder B; Auffray C
Methods Mol Biol; 2016; 1386():43-60. PubMed ID: 26677178
[TBL] [Abstract][Full Text] [Related]
54. Beyond base pairs to bedside: a population perspective on how genomics can improve health.
Khoury MJ; Gwinn M; Bowen MS; Dotson WD
Am J Public Health; 2012 Jan; 102(1):34-7. PubMed ID: 22095352
[TBL] [Abstract][Full Text] [Related]
55. Towards a national genomics medicine service: the challenges facing clinical-research hybrid practices and the case of the 100 000 genomes project.
Dheensa S; Samuel G; Lucassen AM; Farsides B
J Med Ethics; 2018 Jun; 44(6):397-403. PubMed ID: 29496751
[TBL] [Abstract][Full Text] [Related]
56. Diagnosing rare diseases: A sociotechnical approach to the design of complex work systems.
Hay GJ; Klonek FE; Parker SK
Appl Ergon; 2020 Jul; 86():103095. PubMed ID: 32342886
[TBL] [Abstract][Full Text] [Related]
57. Genomics and personalised whole-of-life healthcare.
Bauer DC; Gaff C; Dinger ME; Caramins M; Buske FA; Fenech M; Hansen D; Cobiac L
Trends Mol Med; 2014 Sep; 20(9):479-86. PubMed ID: 24801560
[TBL] [Abstract][Full Text] [Related]
58. Beacon v2 and Beacon networks: A "lingua franca" for federated data discovery in biomedical genomics, and beyond.
Rambla J; Baudis M; Ariosa R; Beck T; Fromont LA; Navarro A; Paloots R; Rueda M; Saunders G; Singh B; Spalding JD; Törnroos J; Vasallo C; Veal CD; Brookes AJ
Hum Mutat; 2022 Jun; 43(6):791-799. PubMed ID: 35297548
[TBL] [Abstract][Full Text] [Related]
59. Understanding the Bioinformatics Challenges of Integrating Genomics into Healthcare.
Al Kawam A; Sen A; Datta A; Dickey N
IEEE J Biomed Health Inform; 2018 Sep; 22(5):1672-1683. PubMed ID: 29990071
[TBL] [Abstract][Full Text] [Related]
60. Impacts of national surveillance for uncommon conditions in childhood.
Zurynski YA; Peadon E; Bower C; Elliott EJ
J Paediatr Child Health; 2007 Nov; 43(11):724-31. PubMed ID: 17924937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
